(Press-News.org) Alzheimer's disease is the world’s most common neurodegenerative disease, affecting more than 50 million people globally. Alzheimer’s disease is also among the most fatal, landing as one of the top five causes of death worldwide. However, most currently available treatments are limited to alleviating the disease’s symptoms.
Now, a new study led by Chapman University researchers has explored the efficacy of using two existing Alzheimer’s disease drugs simultaneously to reduce mortality. It is one of the largest and most comprehensive Alzheimer's treatment studies to date.
The study, “Combine use of Donepezil and Memantine increases the probability of five-year survival of Alzheimer’s disease patients”, was released this month in Communications Medicine, finds that combining the use of the two most common Alzheimer’s disease drugs, Donepezil and Memantine, could extend the lives of approximately 303,000 people with Alzheimer's Disease living in the USA beyond five years from diagnosis. The senior author is Cyril Rakovski, Professor and Program Director for the Faculty of Computational and Data Sciences.
The researchers studied the anonymized medical data of 12,744 patients who were diagnosed with Alzheimer's disease, focusing on patients receiving the three most common treatments to treat the disease: the acetylcholinesterase inhibitor Donepezil (28.94%), the NMDA receptor antagonist Memantine (10.7%), and combined use of Donepezil and Memantine (9.11%). Approximately half of the patients (45.54%) received no drug treatment, and this group served as a control. The researchers tracked the patients’ outcomes five years later. They found that the mortality rates for patients on no drug treatment, only using Memantine, and only using Donepezil were 36%, 32%, and 42% higher than combined use, respectively.
Then, the authors implemented advanced statistical techniques to achieve unbiased estimates of treatment effects and ensure the robustness of results. With these analyses in place, they confirmed a significant, beneficial drug-drug interaction, indicating that the combined use of Donepezil and Memantine significantly increased the probability of five-year survival of Alzheimer's disease patients compared to no drug use and single drug use of Memantine and Donepezil. In particular, compared to no drug use, the combined use of Memantine and Donepezil significantly increased the probability of five-year survival by 0.05 (6.4%).
“The research underscores the importance of the combined treatment, suggesting it can extend patients' lives and reduce medical costs,” said the lead author, Dr. Ehsan Yaghmaei. “This comprehensive causal inference study, using a large, high-quality medical database, provides strong evidence for adopting the combined treatment approach to improve patient outcomes and healthcare efficiency.” Dr. Yaghmaei and others at Chapman University collaborated with researchers at UNC Chapel Hill’s School of Medicine, the Children’s Hospital of Orange County (CHOC), and UC Irvine’s School of Medicine.
The findings suggest the importance of re-evaluating current treatment protocols for Alzheimer's disease, and offer hope that this new standard of care could help the millions affected by this devastating disease.
END
New study reveals combined use of Donepezil and Memantine increases the probability of five-year survival of Alzheimer’s disease patients
2024-06-13
ELSE PRESS RELEASES FROM THIS DATE:
Number of over 65s with type 1 diabetes has almost tripled in 30 years
2024-06-13
The number of people aged 65 and older with type 1 diabetes increased from 1.3 million in 1990 to 3.7 million in 2019, while death rates fell 25% from 4.7 per 100,000 population in 1990 to 3.5 in 2019, finds an analysis of data from over 200 countries and regions in The BMJ today.
Overall, the results show that more people with type 1 diabetes are living longer. However, death rates fell 13 times faster in high income countries compared with low and middle income countries, indicating that substantial ...
Brain regions that bias the brain’s response to pleasure in bipolar disorder identified
2024-06-13
Momentary shifts in mood, even those lasting just a matter of seconds, profoundly alter the brain’s response to pleasurable experiences in people with bipolar disorder, finds a new study by UCL researchers.
Previous research shows that mood can make us experience events in more positive or negative light – irrespective of having bipolar disorder. When we are in a good mood, we are drawn to viewing things more favourably – causing the good mood to rollover and gain momentum.
Equally, when we are upset we get drawn into perceiving bad outcomes as even worse, causing us to remain upset or get even more upset.
This “momentum” in mood can bias how we perceive events ...
Researchers in US, Ukraine simulate cell activity at ‘breathtaking’ timescales
2024-06-12
LAWRENCE — A partnership between scientists at the University of Kansas and collaborators in Europe, including war-torn Ukraine, will result in computer models of biological cells likely to hasten health breakthroughs by simulating molecular interactions inside cells with near experimental accuracy at vastly longer timescales than similar efforts.
The research is supported by the National Science Foundation’s IMPRESS-U (International Multilateral Partnerships for Resilient Education and Science System in Ukraine) program that aims to “support excellence in science and engineering research, education, and innovation through international collaboration and ...
NSF CAREER grant to investigate design of fluorescent protein sensors with computer simulations that may aid human health and disease
2024-06-12
DETROIT — Alice Walker, Ph.D., assistant professor of chemistry in the College of Liberal Arts and Sciences at Wayne State University, received a Faculty Early Career Development (CAREER) award from the National Science Foundation to fund her research on applying computational chemistry to the understanding and rational design of new fluorescent protein (FP) sensors.
“A sensor, chemically speaking, is a molecule that turns on or off in response to certain stimuli,” said Walker. “Proteins are good sensors because they have a florescent element; they essentially glow in the dark in response to when it touches something. ...
Study shows politicians deny misdeeds because we want to believe them
2024-06-12
Why do politicians lie and deny when they are caught up in political scandal?
According to a newly published study led by a University of Nebraska–Lincoln political scientist, the answer may be that their supporters prefer a less-than-credible denial to losing political power and in-group status because of a discredited standard-bearer.
“The driving question of our research is whether people are actually incentivizing politicians to deny wrongdoing and escape accountability,” said Pierce Ekstrom, assistant professor of political science at Nebraska.
“Certainly, there’s a very strong norm ...
Case study reveals important new details about rare second cancers related to CAR-T therapy
2024-06-12
WASHINGTON – A new detailed analysis of a patient’s second cancer after receiving CAR-T therapy for the initial cancer provides rare but important insights intended to offer helpful guidance for oncologists and pathologists about the clinical presentation and pathologic features involved in a CAR-T related second cancer.
The finding is reported June 13, 2024, in the New England Journal of Medicine.
CAR-T therapy is described by many as a new and promising treatment for blood cancers. CAR-T therapy is made from a patient’s ...
Risk of secondary cancers after CAR-T cell therapy low, according to large Stanford Medicine study
2024-06-12
A large study by researchers at Stanford Medicine has found that the risk of secondary blood cancers after CAR-T cell therapy — a cell-based cancer treatment that exploded on the scene in 2017 as a treatment for intractable blood cancers — is low, despite a Food and Drug Administration warning.
In November 2023, the FDA issued a warning about a risk of secondary cancers — particularly blood cancers — that may be associated with CAR-T cell therapy. The warning was preceded by a rising tide of ...
Mouse study identifies unique approach for preventing life-threatening complications after spinal cord injury
2024-06-12
COLUMBUS, Ohio – In response to stressful or dangerous stimuli, nerve cells in the spinal cord activate involuntary, autonomic reflexes often referred to as “fight or flight” responses.
These protective responses cause changes in blood pressure and the release of stress hormones into the blood stream. Normally, these responses are short-lived and well-controlled, but this changes after a traumatic spinal cord injury.
A first-ever study published in the journal Science Translational Research identifies a ...
Western agricultural communities need water conservation strategies to adapt to future shortages
2024-06-12
Reno, Nev. (June 12, 2024) – The Western U.S. is heavily reliant on mountain snowpacks and their gradual melt for water storage and supply, and climate change is expected to upend the reliability of this natural process. Many agricultural communities in this part of the country are examining ways to adapt to a future with less water, and new research shows that a focus on supplementing water supply by expanding reservoir capacity won’t be enough to avert future water crises.
Led by scientists at the Desert Research Institute ...
Does having a child with low birth weight increase a person’s risk of dementia?
2024-06-12
EMBARGOED FOR RELEASE UNTIL 4 P.M. ET, WEDNESDAY, JUNE 12, 2024
MINNEAPOLIS – People who give birth to infants less than 5.5 pounds may be more likely to have memory and thinking problems later in life than people who give birth to infants who do not have a low birth weight, according to a study published in the June 12, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology. The effect on memory and thinking skills was equivalent to one to two years of aging for those with low-birth-weight deliveries.
The study does not prove that delivery of a low-birth-weight ...